Results 121 to 130 of about 5,389 (188)
Management of cirrhotic cardiomyopathy
Cirrhotic cardiomyopathy (CCM) refers to the structural and functional changes in the heart leading to systolic, diastolic, electrocardiographic, and neurohormonal disorders associated with liver cirrhosis and portal hypertension. It is characterized by impaired left ventricular systolic and diastolic dysfunction and electrophysiological abnormalities,
S. M. Chooklin +2 more
openaire +1 more source
What's New in Cirrhotic Cardiomyopathy?-Review Article. [PDF]
Bodys-Pełka A +4 more
europepmc +1 more source
Molecular weight heterogeneity of plasma-ANF in cardiovascular disease [PDF]
Arendt, Rainer M. +3 more
core +1 more source
Value of red blood cell distribution width in prediction of diastolic dysfunction in cirrhotic cardiomyopathy. [PDF]
Chen YL, Zhao ZW, Li SM, Guo YZ.
europepmc +1 more source
Cirrhotic cardiomyopathy: pathophysiology, assessment, and implications for liver transplantation. [PDF]
Gill M +4 more
europepmc +1 more source
Diagnosis and Management of Cirrhotic Cardiomyopathy. [PDF]
Kaur H, Premkumar M.
europepmc +1 more source
Inflammation and Mitochondrial Dysfunction in Cirrhotic Cardiomyopathy: Therapeutic Implications. [PDF]
Ding Y +6 more
europepmc +1 more source
Cirrhotic cardiomyopathy: Appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes. [PDF]
Spann A +10 more
europepmc +1 more source

